CATALOGO DEI PRODOTTI DELLA RICERCA

BERTOLDO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.675
NA - Nord America 4.661
AS - Asia 2.002
SA - Sud America 46
AF - Africa 18
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.648
GB - Regno Unito 1.914
CN - Cina 1.201
SG - Singapore 597
IT - Italia 433
SE - Svezia 424
FR - Francia 392
RU - Federazione Russa 392
IE - Irlanda 321
DE - Germania 307
FI - Finlandia 303
UA - Ucraina 102
TR - Turchia 56
BR - Brasile 30
ID - Indonesia 22
JP - Giappone 21
VN - Vietnam 21
HK - Hong Kong 20
NL - Olanda 16
RO - Romania 16
BE - Belgio 15
KR - Corea 15
CA - Canada 11
CZ - Repubblica Ceca 10
IN - India 10
AU - Australia 9
IR - Iran 9
CL - Cile 7
MY - Malesia 6
EG - Egitto 5
ES - Italia 5
TG - Togo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HU - Ungheria 4
IL - Israele 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
AR - Argentina 3
HR - Croazia 3
LV - Lettonia 3
BD - Bangladesh 2
BG - Bulgaria 2
CO - Colombia 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
IQ - Iraq 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SL - Sierra Leone 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 11.417
Salva come PNG Salva come JPEG
Città #
Southend 1.775
Jacksonville 978
Chandler 816
Singapore 471
Ann Arbor 388
Woodbridge 377
Dublin 318
Houston 310
Ashburn 232
Princeton 149
Lawrence 148
Wilmington 137
Beijing 126
Nanjing 124
Jinan 108
Verona 98
Shenyang 97
New York 82
Hebei 74
Sindelfingen 69
Changsha 65
Helsinki 62
Milan 59
Boardman 55
Nanchang 52
Ningbo 48
Tianjin 47
Zhengzhou 39
Bologna 37
Haikou 35
Jiaxing 33
Taizhou 32
Hangzhou 28
Dearborn 27
Lancaster 24
Jakarta 22
Moscow 20
Falls Church 19
Tokyo 19
Norwalk 18
San Francisco 18
Chicago 17
Dong Ket 16
Fuzhou 16
Brussels 15
Detroit 15
London 15
Paris 15
Taiyuan 15
Guangzhou 14
Santa Clara 14
Seattle 14
Seoul 14
Los Angeles 12
Redmond 12
Rome 12
Washington 11
Fairfield 10
Hong Kong 10
Lanzhou 10
Dallas 9
Cambridge 8
Florianópolis 8
Auburn Hills 7
Bârlad 7
Düsseldorf 6
São Paulo 6
Tübingen 6
Amsterdam 5
Brno 5
Clearwater 5
Des Moines 5
Kent 5
Las Vegas 5
Leawood 5
Lomé 5
Maple Grove 5
Messina 5
Novokuznetsk 5
Capannoli 4
Catania 4
Central 4
Elora 4
Hefei 4
Melbourne 4
Naples 4
Olomouc 4
Pioltello 4
Redwood City 4
Riva 4
Tombolo 4
Toronto 4
Berlin 3
Binasco 3
Bratislava 3
Canberra 3
Costa Mesa 3
Dongguan 3
Esslingen am Neckar 3
Frankfurt am Main 3
Totale 8.081
Salva come PNG Salva come JPEG
Nome #
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. 149
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 145
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 144
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 140
Incidenza di ipovitaminosi D nel Nord Italia 136
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells 130
STEAP mRNA detection in serum of patients with solid tumours. 127
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells 126
Age-related bone loss in postmenopausal women 120
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 119
Bone metabolism in patients with anorexia nervosa and amenorrhoea 117
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 116
BISPHOSPHONATES DECREASE HTERT IN PC3 AND DU-145 PROSTATE CANCER CELLS 115
Bone development during GH and GnRH analog treatment 114
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 111
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 110
Adipocytes IGFBP-2 expression in prepubertal obese children. 110
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 109
The renal handling of calcium: influence of parathyroid hormone secretion 106
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 106
Guidelines for the diagnosis, prevention and management of osteoporosis 106
Bone Microarchitecture in Mild Primary Hyperparathyroidism 102
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 101
Blood ionized calcium is associated with clustered polymorphism in the carboxyl-terminal tail of the calcium-sensing receptor. 101
Osteopenia induced by immunosuppressive drugs in rats. Histomorphometric analisys of risedronate effects. 101
Incidenza di ipovitaminosi D nel Nord Italia 101
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus Deflazacort. 101
Bone microarchitecture evaluated by histomorphometry 100
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? 99
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. 98
YEARS BOOK 2006 . BISFOSFONATI E ONCOLOGIA 98
Altered bone metabolism in children infected with human immunodeficiency virus. 97
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 96
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 95
GAPDH: CONSTITUTIVE HOUSEKEEPING GENE OR TARGET FOR THERAPEUTIC INTERVENTION? 94
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 94
PEAK BONE MASS AND BODY COMPOSITION IN PRECOCIOUS PUBERTY AFTER GNRH AGONIST THERAPY WITH AND WITHOUT CALCIUM SUPPLEMENTATION 94
Bone mineral density and metabolism in HIV-infected children 93
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 93
Bisfosfonati e metastasi ossee:up-to-date 2005 92
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 92
Drug-induced osteonecrosis of the jaw: the state of the art 91
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 89
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 89
EFFETTO DI UN AGONISTA DEL GNRH AD AZIONE PROLUNGATA (LEUPROLIDE ACETATO) SULLO STATO DI MINERALIZZAZIONE OSSEA IN BAMBINE CON PUBERTA' PRECOCE 88
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 88
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 88
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 88
Transdermal Estradiol in the treatment of postmenopausale bone loss. 87
Histomorphometric analysis of glucocorticoid-induced osteoporosis 87
CALCIUM SUPPLEMENTATION, OESTROGENS AND BONE DENSITY IN GNRHA TREATED PRECOCIOUS PUBERTY 86
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 86
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 86
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 86
Final peak bone mass in precocious puberty after GhRH agonist therapy with and without calcium supplementation 85
Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone. 85
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) 84
The prevention of corticosteroid-induced osteoporosis with nandrolone decantate Bone and Mineral 15, 72-81 (1991) 83
emerging drugs for the management of cancer treatment induced bone loss 83
The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study 83
Sodium requirements regulates renal tubular reabsorption of calcium 82
The Effect of Bisphosphonates on Gene Expression: The GAPDH as a Housekeeping or a New Target Gene? 81
Transdermal estradiol in the treatment of postmenopausal bone loss. 81
The use of dichloromethylene bisphosphonate and aminobutanebisphosphonate in hypercalcemia of malignancy. 81
intramuscolar neridronate in postmenopausal women with low bone mineral density 81
Valutazione della microarchitettura ossea nell'iperparatiroidismo primitivo 80
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiopathic hypercalcemia and with primary hyperparathyroidism 80
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 80
Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. 80
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 79
ARTROPATIE DISMETABOLICHE 79
Ruolo dei bisfosfonati nella terapia dell'osteoporosi 77
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic 77
Artropatie dismetaboliche 77
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiophatic hypercalciuria and primary hyperparathyroidism 76
HIV-infected children and bone mineral density 75
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteopororis fractures 75
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. 75
Effects of two oral doses of alendronate in the treatment of Paget’s Disease of bone 75
Obesità e osteoporosi 75
Osteomalacia: The missing link in the pathogenesis of Bisphosphonate-related osteonecrosis of the jaws? 75
nUOVE PROSPETTIVE NELL'UTILIZZO DEI BISFOSFONATI IN ONCOLOGIA:OLTRE LA METASTASI OSSEA 74
Calcium Supplementation Increases Bone Mass in GH-Deficient Prepubertal Children during GH Replacement 73
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 73
L'osteoporosi cortisonica 72
Can we consider zoledronic acid a new antitumor agent? Recent evidence in clinical setting 72
Trabecular bone microarchitecture in mild primary hyperparathyroidism 71
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 70
Serum 25-hydroxy vitamin D and exercise capacity in COPD. 69
Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools. 69
Effetto dell'alendronato sulle caratteristiche strutturali e biomeccaniche dell'osso corticale 68
Intramuscular neridronate in postmenopausal women with low bone mineral density 68
Physiopatology of bone metastases 68
Prevenzione della demineralizzazione ossea mediante supplementazione con calcio durante il trattamento con agonisti del GnRH nella pubertà precoce 67
Valutazione della perdita frazionaria di massa ossea dopo la menopausa. 67
Fisiopatologia del dolore da metastasi ossea 67
Biology and Pathophysiology of Bone Metastasis in Prostate Cancer 67
Bone Metastases from Prostate Cancer.Biology, Diagnosis and Management 67
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS). 66
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 66
Totale 9.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.988
article - articoli 35.245
book - libri 756
conference - conferenze 2.098
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.889
Totale 79.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020907 0 0 0 0 114 137 139 130 71 116 26 174
2020/20211.194 123 197 39 136 153 125 25 108 112 6 132 38
2021/20221.251 96 389 6 101 48 48 14 61 39 27 122 300
2022/20232.308 218 196 274 364 227 524 12 134 240 24 73 22
2023/20241.191 53 89 131 135 170 169 59 74 7 50 159 95
2024/20251.133 188 199 113 478 155 0 0 0 0 0 0 0
Totale 11.553